End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
788,000 KRW | +0.51% | +0.13% | +3.68% |
May. 06 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
Apr. 25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- MarketScreener Editorial Features